Replies to post #52662 on Amarin Corp Plc (AMRN)

[Sam81]

John, i guess this shows that once approved in China, V will be better accepted and have an impact way more than in the US bcz of the FDA political stand and role and most of all corruption. China will turn out to be a way bigger market than the USA and hopefully the struck deal with Eddingpharm will be reflected in teh financials and stock price in the medium term

[jessellivermore]

zum..

great article...maybe copies should be sent to the E-M division of FDA. But probably a waste of time since no one at FDA bothers reading the literature.

Particularly interesting is the section on tumor protection.

Thanks for posting

":>) JL

[couldbebetter]

My hope is that the Chinese medical establishment will be rational and Vascepa will end up becoming a blockbuster medication there. The unknown is how well Edingpharm will perform and exactly when Vascepa will be available over there. With over 100 million diabetics the need should be higher than here in the US. Seems as if you have posted numerous articles on EPA authored by Chinese doctors. I do believe you are correct, they do "get it."